Shire announces revised proposal and extension of PUSU deadline to 8 May 2018 Pharmaceutical Investing
Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone Pharmaceutical Investing
Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series Pharmaceutical Investing
Alder BioPharmaceuticals Presents New 12-Month Data of Eptinezumab in PROMISE 1 Phase 3 Trial Showing Long-Term Reduction in Episodic Migraine Biotech Investing
Precision Therapeutics Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares Pharmaceutical Investing
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA Pharmaceutical Investing
Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin Pharmaceutical Investing
